140 related articles for article (PubMed ID: 35702119)
1. Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer.
Zhang W; Liu H; Jiang J; Yang Y; Wang W; Jia Z
Am J Transl Res; 2022; 14(5):2952-2961. PubMed ID: 35702119
[TBL] [Abstract][Full Text] [Related]
2. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q
Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825
[TBL] [Abstract][Full Text] [Related]
3. CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.
Liu M; Tsang JYS; Lee M; Ni YB; Chan SK; Cheung SY; Hu J; Hu H; Tse GMK
J Clin Pathol; 2018 Nov; 71(11):1007-1014. PubMed ID: 30099407
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
5. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.
Yuan Y; Shen N; Yang SY; Zhao L; Guan YM
Oncol Lett; 2015 Jul; 10(1):342-348. PubMed ID: 26171027
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
[TBL] [Abstract][Full Text] [Related]
9. [Expression of CD147 and matrix metalloproteinase-9 in children with non-Hodgkin's lymphoma and its correlation with prognosis].
Liu AG; Hu Q; Tao HF; Liu SY; Zhang LQ; Hu Y
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):785-8. PubMed ID: 20021816
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.
Wang RX; Chen S; Huang L; Shao ZM
BMC Cancer; 2018 Sep; 18(1):909. PubMed ID: 30241470
[TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
[TBL] [Abstract][Full Text] [Related]
12. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis.
Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q
Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer.
Ding F; Chen RY; Hou J; Guo J; Dong TY
World J Clin Cases; 2022 Apr; 10(12):3698-3708. PubMed ID: 35647172
[TBL] [Abstract][Full Text] [Related]
14. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
16. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
17. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
19. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD147 and MMP-2 in human gliomas and its correlations with prognosis].
Li H; Chen J; He M; Hui XH; Cai BW; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):396-9. PubMed ID: 17593815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
